Novaliq GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Novaliq GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7589
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Novaliq GmbH (Novaliq) is a drug delivery company that develops pharmaceutical formulations. The company develops dermatological products, novel ophthalmic, and solutions for organ preservation based on the physicochemical properties of semifluorinated alkanes. It offers NovaTears a preservative free eye drop product for the relief of discomfort under dry eye syndrome. Novaliq also produces pipeline products for the treatment of glaucoma and other retinal diseases. The company offers its SFA technology as a delivery platform for external co-development cooperations. It licenses its SFA technology to distribution partners who completes registration studies. Novaliq is headquartered in Heidelberg, Germany.

Novaliq GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Novaliq GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novaliq GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Novaliq GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novaliq GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Novaliq GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Novaliq GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Novaliq GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Novaliq Raises USD53 Million in Venture Financing 11
Novaliq Raises US$18 Million In Venture Financing 12
Novaliq Raises US$5.2 Million In Venture Financing 13
Partnerships 14
Novaliq Enters into Partnership with University of Cologne 14
Licensing Agreements 15
AFT Pharma Enters into Licensing Agreement with Novaliq 15
URSAPHARM Enters into Licensing Agreement with Novaliq 16
Novaliq GmbH – Key Competitors 17
Novaliq GmbH – Key Employees 18
Novaliq GmbH – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
Jun 27, 2017: NOVALIQ Strengthens Executive Management Team with the Appointment of Gabriela Burian, MD, MPH, as Chief Medical Officer 20
Product News 21
10/02/2017: German Ophthalmological Society (DOG) Honors Uta Gehlsen, PhD, with Prestigious Scientific Award for Her Research on the Use of Semifluorinated Alkanes in Dry Eye Treatment 21
Clinical Trials 22
Nov 09, 2017: Novaliq announces first patient randomized in its ESSENCE phase 2b/3 trial of CyclASol for the treatment of the signs and symptoms of dry eye disease 22
Jan 05, 2017: Novaliq Announces Positive Topline Results of Phase 2 Clinical Trial Evaluating CyclASol in Adults with Moderate to Severe Dry Eye Disease 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Novaliq GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Novaliq GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novaliq GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Novaliq GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novaliq GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Novaliq GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Novaliq GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Novaliq Raises USD53 Million in Venture Financing 11
Novaliq Raises US$18 Million In Venture Financing 12
Novaliq Raises US$5.2 Million In Venture Financing 13
Novaliq Enters into Partnership with University of Cologne 14
AFT Pharma Enters into Licensing Agreement with Novaliq 15
URSAPHARM Enters into Licensing Agreement with Novaliq 16
Novaliq GmbH, Key Competitors 17
Novaliq GmbH, Key Employees 18

List of Figures
Novaliq GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Novaliq GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Novaliq GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Novaliq GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Novaliq GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novaliq GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Novaliq GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novaliq GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Novaliq GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Novaliq GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sinofert Holdings Ltd (297):企業の財務・戦略的SWOT分析
    Sinofert Holdings Ltd (297) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Hogan Lovells International LLP:企業の戦略的SWOT分析
    Hogan Lovells International LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Andalay Solar Inc (WEST):企業の財務・戦略的SWOT分析
    Andalay Solar Inc (WEST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • BAB, Inc.:企業の戦略・SWOT・財務情報
    BAB, Inc. - Strategy, SWOT and Corporate Finance Report Summary BAB, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Jubilee Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    Jubilee Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Jubilee Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Nexans SA (NEX):電力:M&Aディール及び事業提携情報
    Summary Nexans SA (Nexans) is a provider of cables and connectivity solutions. The company offers copper and fiber optic cables and cabling systems. It serves network operators, equipment and infrastructure manufacturers, and builders, installers and distributors in submarine and land, oil and gas, …
  • AB Orlen Lietuva:企業の戦略的SWOT分析
    AB Orlen Lietuva - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Cell Therapy Catapult Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cell Therapy Catapult Ltd (Catapult) is a provider of cell and gene therapy life cycle solutions. The company offers services such as industrialization, manufacturing, regulatory, health economics and market access, non-clinical safety and clinical operations. Its health economics and market …
  • Calumet Specialty Products Partners LP (CLMT):企業の財務・戦略的SWOT分析
    Calumet Specialty Products Partners LP (CLMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Evraz Plc:企業のM&A・事業提携・投資動向
    Evraz Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Evraz Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Overseas Shipholding Group Inc (OSG):企業の財務・戦略的SWOT分析
    Overseas Shipholding Group Inc (OSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Consolidated Edison Development Inc:電力:M&Aディール及び事業提携情報
    Summary Consolidated Edison Development Inc (CED), a subsidiary of Consolidated Edison Inc, is an energy company that develops, owns and operates renewable and energy infrastructure projects. The company operates solar photovoltaic projects and wind farms. It operates energy storage and energy pipel …
  • Zebra Technologies Corporation:企業の戦略・SWOT・財務情報
    Zebra Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Zebra Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Randstad Holding NV (RAND):企業の財務・戦略的SWOT分析
    Randstad Holding NV (RAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Larsen & Toubro Limited (LT):電力:M&Aディール及び事業提携情報
    Summary Larsen & Toubro Limited (L&T) is an industry conglomerate which carries out technology, engineering, construction and manufacturing activities. It offers a broad spectrum of design-to-deliver solutions. Its service portfolio includes basic and detailed engineering, erection and commissioning …
  • Amara Holdings Ltd:戦略・SWOT・企業財務分析
    Amara Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Amara Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CVR Energy Inc (CVI):石油・ガス:M&Aディール及び事業提携情報
    Summary CVR Energy Inc (CVR Energy) is a diversified holding company that specializes in refining of crude oil and manufacturing of nitrogen fertilizer. It produces and sells high value transportation fuels such as gasoline, diesel, jet fuel, and gas oil. The company also produces pet coke and other …
  • C. Uyemura & Co Ltd (4966):企業の財務・戦略的SWOT分析
    C. Uyemura & Co Ltd (4966) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Fichtner GmbH & Co KG:企業の戦略的SWOT分析
    Fichtner GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Lycera Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Lycera Corp (Lycera) is a biopharmaceutical company that focuses on the development of oral immune modulators for the treatment of patients with autoimmune diseases and cancer. The company’s pipeline products include LYC-55716, an oral retinoic acid-related orphan receptor gamma (RORgamma) a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆